Listen "Scrip's Five Must-Know Things - Nov. 4, 2025"
Episode Synopsis
Audio roundup of selected biopharma industry content from Scrip over the business week ended October 31, 2025. In this episode: third quarter dealmaking picks up; Novartis still has M&A firepower even after Avidity acquisition; Hanmi’s obesity contender shows Phase III promise; NVIDIA partnership progresses Lilly’s AI plans; and Lilly builds gene therapy push with Adverum buy.
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-MQMX2YHSAVHBTJFR4RAEAYNFNQ/
This episode was produced with the help of AI text-to-voice and voice emulation tools.
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-MQMX2YHSAVHBTJFR4RAEAYNFNQ/
This episode was produced with the help of AI text-to-voice and voice emulation tools.
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.